Project Grant 20226701736240
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The University of Texas Southwestern Medical Center a Project Grant of $653,123 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a multi-centric randomized controlled trial comparing two treatment approaches for recurrent urinary tract infections (rUTIs) in women. The award, effective September 1, 2025, through June 30, 2030, will...
- Federal Grant Award Summary Watershed Medical Inc. received a $647,700 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 17, 2025, with a completion date of September 16, 2026. The award supports the development of a novel bladder-targeted drug delivery platform designed to treat recurrent urinary tract infections (RUTIs) in postmenopausal women. The therapeutic approach utilizes...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $610,124 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026 through January 31, 2031. The grant supports investigator-initiated research focused on developing BCG (Bacillus Calmette-Guerin) mediated immunotherapy as an alternative treatment strategy for recurrent...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,618,854 Project Grant on September 9, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on catheter-associated urinary tract infection (CAUTI) pathogenesis. The research, titled "Impact of Polymicrobial Interactions and Within-Host Adaptation on CAUTI Pathogenesis," will be conducted through June 30,...
- GRANT AWARD SUMMARY Baylor College of Medicine received a $3.00 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 15, 2025, through August 31, 2029. The award funds fundamental research investigating the mechanisms underlying age- and sex-dependent changes in urinary bladder immunity, with particular focus on understanding...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $234,000 Project Grant (R21) to the University of South Alabama under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 7, 2026, with completion scheduled for April 30, 2028. This early-stage research project investigates the novel hypothesis that bacterial infection triggers the accumulation of amyloid-beta (Aβ) peptides in the kidney to drive deleterious...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded a $458,616 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of Texas at Dallas, effective September 15, 2025, through August 31, 2027. The award funds research investigating the impact of estrogen hormone therapy modality on urobiome dynamics in postmenopausal women, with emphasis on reducing recurrent urinary tract infections (UTIs). The research...
- This $414,781 Project Grant awarded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support research to investigate the effects of pelvic radiotherapy on the urinary microbiome and its potential as a biomarker for radiation cystitis in prostate cancer patients. The primary awardee, the University of Rochester, will use banked urine samples from a clinical study, as well as a preclinical mouse model, to test hypotheses that: 1) radiotherapy alters the microbial...
- Federal Project Grant Award Summary The University of California, Irvine received a $863,500 Project Grant award dated September 18, 2025, through the Trans-NIH Research Support program (CFDA 93.310) administered by the National Institutes of Health Office of the Director. The award supports research investigating anti-fibrogenic therapeutic approaches to address aging-associated urethral dysfunction and urinary incontinence in women. The research will be conducted through August 31, 2027, and...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $717,957 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective March 1, 2026, through February 28, 2031. The award funds research investigating estrogen signaling mechanisms in urinary tract infection (UTI)-related delirium, a significant clinical complication affecting tens of millions of Americans annually with healthcare costs exceeding $152 billion per year. The research...
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** THE AMERICAN CRANBERRIES, ESPECIALLY CRANBERRY JUICE, HAVE BEEN USED FOR CENTURIES AS A FOLK MEDICINE TO PREVENT URINARY TRACT INFECTIONS (UTI), WHICH AFFECT 50% OF WOMEN IN THEIR LIFETIME. OVER 30 CLINICAL TRIALS HAVE BEEN CONDUCTED IN THE LAST 20 YEARS TO VERIFY THE UTI PREVENTATIVELY ACTIVITY OF CRANBERRY JUICES, BUT THE RESULTS WERE CONTRADICTORY. ABOUT 90% OF UTI ARE INITIATED BY THE ADHESION OF UROPATHOGENIC E. COLI (UPEC) ON URINARY TRACT EPITHELIA. IT WAS REPORTED THAT HUMAN URINE AFTER CONSUMPTION OF CRANBERRY JUICE INHIBITED THE ADHESION OF UPEC. THE A-TYPE PROANTHOCYANIDINS AND XYLOGLUCANS ARE THE PRESUMED BIOACTIVES IN CRANBERRIES, HOWEVER, THIS IS UNLIKELY BECAUSE THESE TWO CLASSES OF COMPOUNDS HAVE EXTREMELY LOW BIOAVAILABILITY IN HUMAN BODY. PRELIMINARY RESEARCH SUGGESTED THAT WOMEN CAN BE EITHER RESISTANT OR SUSCEPTIBLE TO UTI DEPENDING ON THE INHERENT ANTI-ADHESION ACTIVITY IN THEIR URINE AGAINST UPEC BEFORE CONSUMING CRANBERRY JUICE. NOT ALL BUT A FRACTION OF UTI SUSCEPTIBLE WOMEN HAD INCREASED URINARY ANTI-ADHESION ACTIVITY AFTER CONSUMING CRANBERRY JUICES. THESE WOMEN ARE CLASSIFIED AS RESPONDERS AND OTHERS ARE NON-RESPONDERS. THE VARIATION OF GUT MICROBIOME IS A PROBABLE MECHANISM FOR METABOLIC POLYMORPHISMS AND DISPARITY IN UTI PREVENTION. THE OBJECTIVE OF THIS TRIALS IS TO IDENTIFY GUT MICROBES AND ANTI-ADHESIVE URINARY BIOMARKERS WHICH SIGNIFICANTLY CONTRIBUTE TO THE ANTI-ADHESION OF UPEC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/13/26 | ||
| Not listed | $650.0k | 11/9/21 |